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INTRODUCTION 
Ruptured abdominal aortic aneurysm (rAAA) is a surgical emergency for which 
anesthesia as a specialty has developed a more or less classic textbook 
approach.1 However, recent initiatives such as the Abdominal Aortic Aneurysm 
Quality Improvement Programme (AAA QIP), 2   the centralization of vascular 
services in the United Kingdom (UK) and the Immediate Management of Patients 
with Ruptured Aneurysm: Open Versus Endovascular Repair (IMPROVE) trial 3 
have challenged some of our traditional perceptions of the optimal anesthetic 
management of rAAA in contemporary practice. This review focuses on all the 
factors involved in modern day anesthesia for rAAA, including the impact of 
centralization, different surgical and anesthetic techniques, including the use of 
local anesthesia only for endovascular aneurysm repair (EVAR), perioperative 
resuscitation and fluid management. 
 
EPIDEMIOLOGY 
The prevalence of abdominal aortic aneurysm (AAA) in men between the ages of 
65-74 is 5-7%, rising to >10% in those over 74. 4 Ruptured abdominal aortic 
aneurysm (rAAA) is the 13th commonest cause of death in the UK, responsible 
for 8,000 deaths per year. 5 In England and Wales alone, around 1200 repairs 
from rAAA are performed annually. 6 Despite a large reduction in mortality from 
rAAA at population level from 65.9 to 44.6 per 100,000 since the mid 1990?s,6 
(largely due to a reduction in smoking prevalence and improved medical 
treatment), mortality, once rupture has occurred, remains high.  With variation 
between different healthcare systems and countries, mortality ranges from 53 to 
90%. 7 Without repair, the condition has almost 100% mortality within 3 days. 8 
 
DIAGNOSIS OF RUPTURED AAA 
Ruptured AAA is an emergency that requires rapid and efficient preoperative 
evaluation and decision-making. Clinical signs and symptoms of rAAA vary from 
abdominal or back pain, in the presence of a pulsatile abdominal mass, to shock 
and cardiovascular collapse. 1 The diagnosis can be difficult, especially in elderly 
patients with multiple co-morbidities.  A clinical diagnosis of rAAA by a senior 
emergency medicine clinician is sufficient to prompt referral and transfer to a 
specialist vascular center. Ultrasonography is helpful to diagnose the presence 
of an AAA, but it cannot diagnose rupture. Computed tomography (CT) is the 
most helpful special investigation to diagnose rAAA, but it should never delay 
patient transfer to a specialist vascular center.  It is preferable to perform the CT 
in a vascular center rather than delay transfer. 9,10  
 
TRANSFER OF PATIENTS WITH rAAA TO SPECIALIST VASCULAR 
CENTRES 
The best short and medium term outcomes in rAAA are seen in hospitals with 
larger bed numbers, 7 larger rAAA case volume (threshold of 15 rAAA?s per 
year), 5,11  higher levels of surgical skill (surgeons maintaining higher volumes of 
vascular work have lower mortality rates) 12 and specialized vascular 
anesthetists. 13 
 Centralization of specialist vascular services and recognition of vascular surgery 
as an independent specialty since 2012 are initiatives brought about as part of 
AAA QIP, set up by the Vascular Society of Great Britain and Ireland (VSGBI). 13 
This was prompted by an international comparison of perioperative mortality after 
elective AAA surgery that showed that the UK had a high mortality rate 
compared to the rest of Western Europe. 14  More recent evidence from 
comparative studies confirms further international disparity also with regards to 
rAAA. 7 European data suggests that streamlined regional pathways improve 
outcomes for patients with rAAA.15 Widely varied practices for transfer of patients 
with rAAA in England led to a three-round Delphi consensus approach 16 and 
also the publication of the joint best practice guidelines for the management and 
transfer of patients with a diagnosis of rAAA to a vascular center from the 
VSGBI, the College of Emergency Medicine and the Royal College of 
Radiologists.17 Transfer of patients should be as swift and streamlined as 
possible; a paramedic crew is preferred but not essential; intravenous access 
and continuous vital sign monitoring is required before transfer; aggressive fluid 
resuscitation should be avoided and no blood products should be transferred 
with the patient.  The clinical diagnosis of rAAA does not have to be supported by 
any investigations that could delay transfer to a specialist vascular center. 
Transfer is contra-indicated in patients who have had a cardiac arrest during the 
current admission. 9,10 Figure 1 is a suggested pathway for decision-making and 
management of the transfer of patients who present with rAAA. An audit 
standard stating that appropriate patients with rAAA should be transferred to the 
nearest specialist vascular unit within 30 minutes after diagnosis, was introduced 
with the above guidelines.10 
 
Treatment of patients with rAAA at specialist centers with significant volume and 
extensive experience may result in an increased acceptance of high-risk patients 
for surgical intervention.  Although this might not reduce perioperative mortality, it 
could reduce overall mortality in rAAA, because no surgical intervention nearly 
always leads to death. 17 There is a need to measure the impact of centralization 
via clinical audit and prospective observational studies. 
 
PRE-OPERATIVE MANAGEMENT 
A ruptured AAA is a true surgical and anesthetic emergency and there is limited 
time for preoperative investigations or optimization of modifiable risk factors. 1 A 
rapid preoperative assessment is required to assess functional status, medical 
history and risk stratification as discussed below. In cases of significant 
cardiovascular collapse, immediate transfer to an operating theatre is required. 
However, in most cases there is time for CT angiography to confirm the 
diagnosis and also to assess the aneurysm morphology and possible suitability 
for EVAR. The patient should be monitored and accompanied by trained staff; 
there is a high risk of cardiovascular collapse and moving and rolling of the 
patient should be kept to a minimum. Successful resuscitation and anesthetic 
management often requires two anesthetists: in the initial phase one anesthetist 
to treat the patient while the other oversees the preparation of the operating 
theatre, drugs and cell saver. The pathway from presentation to the operating 
theatre is illustrated in figure 2. 
 
Risk Stratification & Patient Selection 
Early assessment of co-morbidities and unmodifiable risk factors 18 must be 
carried out in all patients who present with rAAA, as well as establish whether 
the patient has an advanced directive. They are often elderly with premorbid 
conditions that contribute significantly to perioperative risk. 18 In some clinical 
scenarios attempted surgical intervention would be futile and in an attempt to 
stratify perioperative risk, scoring systems have been applied. 19 (Table 1) 
1) Glasgow Aneurysm Score (GAS). A cut-off of 84 is currently used to signify 
high mortality; patients with a GAS <84 had a 30-day mortality of 28.2% 
compared to 65% in those with a score >84. 20 
2) Hardman Index. Most commonly used and seen as the gold standard in 
rAAA.21 Systolic Blood Pressure (SBP) is not directly taken into account at 
presentation but the index is easy to calculate and well validated. It is also the 
only scoring system to be validated for rAAA for both operative and EVAR repair 
and for both immediate and 30-day mortality. 21 
3) Acute Physiology & Chronic Health Evaluation (APACHE II). This scoring 
system has long been used to assess disease severity in the critically ill. 22 It 
must have all variables submitted, therefore can be limiting or potentially cause 
delay. It is the only one of the scoring systems discussed here, which includes 
an assessment of chronic disease, however points are only scored if the disease 
is severe. It is not specific to rAAA and studies are conflicting in its validation in 
this population. 23,24 
4) Physiological and Operative Severity Score for the enUmeration of 
Mortality and morbidity (POSSUM). This combines physiological and operative 
variables. Further POSSUM equations have been developed and validated 
specifically for vascular surgery and rAAA (V-POSSUM and RAAA-POSSUM 
respectively). 25 
Risk prediction scoring systems have limitations and should only be used in 
conjunction with clinical judgment. A recent paper has shown that GAS ≥ 96 was 
associated with poor long-term survival but > 20% of these patients survived 1 
year. 26 None of the risk scoring systems currently in use provides reliable 
guidance to clinicians regarding decision to treat. It is also important to consider 
the contribution of factors, not included in current scoring systems, to prognosis, 
for example, the anatomical features of the aneurysm neck. The following 
features make the neck less suitable for repair by endovascular approach but 
unfortunately also increase mortality at open repair, therefore are independent 
predictors of mortality: 1) inappropriate zones for graft implantation (extreme 
calcification / thrombus); 2) proximal neck <10-15mm 3) angulation >60 degrees. 
21,27-29 
 
 
 
Hemodynamic and fluid management 
Traditionally, guidelines on the preoperative emergency management of patients 
with rAAA have always recommended the use of ?permissive hypotension? in 
order to limit further blood loss. Target SBP being 50-100mmHg, unless signs of 
cerebral or myocardial hypoperfusion are seen. 30,31 However, recent evidence 
from the IMPROVE trial reported a significant association between the lowest 
SBP recorded pre-operatively and 30-day mortality, independent of fluid 
administration. Using a threshold SBP of 70mmHg, 30-day mortality below and 
above this was 51% and 34.1% respectively. 32 A recent meta-analysis of 29 
studies, which defined hemodynamic instability as an SBP <80mmHg or shock 
index >1 also found a significant association with 30-day mortality.33 
Furthermore, a recent retrospective study showed that SBP <70mmHg was also 
associated with larger intraoperative blood loss.34 These studies indicate that 
systolic blood pressure acts as an important prognostic indicator in patients who 
present with rAAA. 
 
Guidelines and teaching on fluid management in rAAA have always been to 
restrict fluid administration pre-aortic clamping for fear of accelerating bleeding 
and dilution of clotting factors.1,9 The most common advice being to give only 
250ml fluid boluses to maintain SBP>70mmHg.35 A recent retrospective study of 
IV fluids given to 248 patients with rAAA (96% underwent OR), showed that 
aggressive IV fluid administration pre-aortic clamping or endovascular sealing 
was associated with increased 30-day mortality (median volume 0.9L/hr pre-
op).36 However, association does not prove causality.  Also, in the IMPROVE 
trial, the effect of volume of fluid administered on 30-day mortality was not 
significant. 32 The potential benefit of decreased bleeding and lessening of 
further rupture should be balanced against the risk of end organ ischemia and 
dysfunction. More clinical studies are needed to provide evidence?based 
recommendations regarding the optimal blood pressure ranges, hemodynamic 
and fluid management for patients who present with rAAA. 
 
INTRA-OPERATIVE MANAGEMENT 
Surgical treatment for rAAA requires a relatively large multidisciplinary team to 
work efficiently. Therefore, good communication between the anesthetic team, 
vascular surgeons, interventional radiologists, emergency department doctors 
and theatre staff is crucial in the effective management of rAAA.  The surgeon 
usually consults the interventional radiologist to make the decision whether the 
surgical approach should be via the open or EVAR route. Open repair is 
performed in an emergency operating theatre while EVAR is performed in a 
hybrid theatre. The immediate goal is control of hemorrhage by the surgical 
and/or interventional radiology team. The operating theatre should be prepared 
with a cell saver, pressurised warmed fluids, ideally through a rapid infuser 
device and ready to be administered through large bore iv cannulae. 1 
Vasopressors and inotropes should also be prepared in advance. 
 
Echocardiography may be useful as a method of detecting the rare complication 
of aortic dissection, which can occur during or after aortic surgery, sometimes as 
a consequence of aortic cross-clamping. Whilst transesophageal 
echocardiography (TEE) is the choice of technique for detecting aortic 
dissection, transthoracic echocardiography (TTE) can also provide useful 
information, as dissection is most often retrograde when caused by aortic 
clamping. 37 Both techniques require an experienced operator and in current UK 
practice, this is not a routinely used as a peri-operative investigative technique in 
non-cardiac surgery. It can however also provide information about dissection 
malperfusion (false and true lumens) by enabling visualization of blood flow. 
Cardiovascular instability may be an indication of dissection. However, evidence 
regarding the use of echocardiography in rAAA is limited. 38,39 
 
Anesthetic Technique 
Induction of anesthesia in these patients is often associated with hemodynamic 
instability. This might be due the effects of anesthetic drugs, reduction in 
sympathetic tone and the loss of muscle tone maintaining tamponade, 
exacerbating intra-abdominal bleeding. Therefore, the patient is only induced 
once prepped and draped and with the surgeon ready to start immediately. 
Invasive blood pressure measurement before induction is ideal, but there should 
be no delay, especially if the patient is unstable. In the UK, a modified rapid 
sequence induction with carefully titrated doses of opiates, induction agents and 
vasopressors are often used. A variety of anesthetic techniques might be 
suitable and there is currently no evidence that certain agents or a specific 
technique is superior.  The main aim is to maintain hemodynamic stability and 
avoid hypotension. Central venous access should be established after induction 
and should not delay surgery.  
 
Local vs. general anesthesia for EVAR 
Studies have shown early on that it is possible to perform EVAR surgery under 
different types of anesthesia including general, neuro-axial and local anesthesia. 
40,41 Currently, choice of anesthesia depends mostly on experience and personal 
choice of the anesthetist. There have been no prospective, randomized trials 
designed to specifically examine the outcomes between general anesthesia (GA) 
vs. local anesthesia (LA). 
Analysis of over 5000 patients from the EUROSTAR database investigating the 
effect of the type of anesthesia on outcome showed a significantly lower 
mortality, morbidity and hospital stay in the group who received regional 
anesthesia (RA) / LA vs. GA. Further analysis of the data indicated that high-risk 
patients in particular, gain from less invasive anesthetic techniques with 
decreased mortality, morbidity, hospital stay and critical care admission in the 
regional/LA group vs. the GA group.42,43 
A subgroup analysis of the IMPROVE trial showed that patients who had 
emergency EVAR surgery for ruptured AAA under LA had a significantly reduced 
odds of 30-day mortality compared to those who had GA (odds ratio 0.27, 95% 
CI 0.10 to 0.70) after adjustment for major potential confounders. 32 A systematic 
review published in 2012 suggested differences in a number of outcomes 
between LA, RA and GA for EVAR, with LA appearing to be the safest option 
and GA the most hazardous. However, the review did not identify any RCTs 
comparing types of anesthesia and the authors were clear that the results could 
be due to confounding with higher risk patients receiving GA.44 Theories about 
the potential causes of poorer outcomes under GA include relaxation of tissues 
and subsequent release of tamponade, as well as the significant hemodynamic 
effects of GA, including a loss in vascular tone, all of which may be exacerbated 
in shocked patients with ruptured AAA. Further studies have been published 
since the 2012 review and EVAR technology has also advanced significantly in 
recent years with the advent of narrow-gauge, ?low-profile? grafts leading to 
increased use of percutaneous techniques under LA. Therefore, there is a need 
for a high quality, adequately powered RCT, specifically comparing the influence 
of anesthetic technique for EVAR on outcomes in rAAA repair.  
 
Surgical Approach: Open vs. EVAR 
Endovascular approach to aneurysm repair was first reported in the early 1990?s 
45 and since then has increased in popularity as it avoids the major physiological 
insult of a laparotomy in this high-risk patient group. Observational studies from 
national datasets suggest that emergency EVAR for rAAA may be associated 
with a lower 30-day mortality rate. 11,46,47 The observational study outcomes may 
be explained by selection bias, whereby surgeons accepted more 
hemodynamically stable patients to undergo EVAR. The recent IMPROVE trial 
was a prospective, 30-center trial, that randomized 600 patients with a clinical 
diagnosis of rAAA to undergo repair by either EVAR or an open approach. They 
reported no significant reduction between the 30-day mortality or cost of the two 
groups.3 A recent individual-patient meta-analysis of three randomized controlled 
trials that compared EVAR versus open repair for rAAA, reported that woman 
might benefit more from the EVAR approach and that patients are discharged 
sooner after EVAR, but survival to ninety days was similar for both groups. 48 
Despite this, earlier discharge from critical care, shorter hospital stay and a much 
higher proportion discharged directly home in the EVAR group means that the 
EVAR approach is likely to gain further support for use in rAAA, especially in 
specialist centers. Furthermore, the EVAR approach for rAAA would increasingly 
allow treatment of more elderly patients and those with significant comorbidities 
who would not be considered feasible candidates for open surgery.7 Not all 
patients are anatomically suitable for EVAR (only about 65%) and even for 
patients who are suitable for EVAR, mortality remains high at about 25%.3  The 
latest guidelines from the European Society for Cardiology recommend either 
open or EVAR surgical approach for patients who present with rAAA suitable for 
EVAR. 49 
 
 
 
 
Hemodynamic control in open AAA 
Careful administration of short-acting vasodilators or opiates can be used to 
control increases in blood pressure that might occur after cross-clamping of the 
aorta. This also allows more aggressive fluid resuscitation via either crystalloid or 
blood products which, in turn, aids preparation for release of the aortic clamp. 
Central venous pressure (CVP), pulse pressure variation via the arterial line or 
non-invasive cardiac output monitoring can be used to guide to intravascular 
filling. 1 Aim for close to normotensive blood pressure.  
Despite these strategies, release of the cross-clamp causes a sudden decrease 
in afterload and concurrent ischemia-reperfusion injury that often cause severe 
hypotension and acid-base disturbances with lactic acidosis. This can be 
managed by gradual release of the clamp and use of positive inotropic agents 
and vasoconstrictors. Optimal management of the application and release of the 
aortic cross-clamp requires good communication between the vascular surgical 
and anesthetic teams. 
There is a high risk of peri-operative cardiac complications.4,11 Intravenous 
nitrate infusions can be used if ischemic changes are visible on the ECG. 
Regular arterial blood gas analysis is used throughout to monitor resuscitation, 
acid-base and electrolyte balance. 
 
Hematology 
Every modern hospital should have a major hemorrhage protocol for the quick 
and appropriate issuing of blood and coagulation products. A recent 
retrospective study showed that lower preoperative fibrinogen concentration and 
platelet count were associated with larger intraoperative blood loss. 34 
Specifically, hypofibrinogenemia (<1.5 g/L) was associated with intraoperative 
blood loss >2L and higher 30-day mortality. 34 
Thromboelastography can reliably indicate fibrinolysis, hypercoagulability and / 
or hypofibrinogenaemia and is used commonly in larger arterial centers to guide 
transfusion practice. Where it is not available, formal laboratory testing of 
coagulation, including INR, platelets and fibrinogen is used. The use of a red cell 
salvage system has dramatically decreased the amount of donor blood 
commonly used in rAAA surgery. There is currently no consensus about red 
blood cell transfusion threshold in either elective or emergency vascular surgery 
and a remarkable lack of randomized controlled trials. 5,50 The UK based,  
National Institute for Health & Care Excellence (NICE) recently published 
guidance, recommending a red blood cell transfusion threshold of 80g/Liter and 
a post-transfusion target hemoglobin of 80-100g/Liter in patients with major 
hemorrhage. 51 However, each patient must be assessed on an individual basis.  
 
  
Thermoregulation 
Hypothermia caused by patient exposure, blood loss and administration of large 
amounts of blood products and resuscitation fluids can have further detrimental 
effects on coagulation. Every attempt should be made to achieve normothermia 
via upper body warm air blankets and warmed fluids. Warm air blankets should 
never be applied to the lower limbs as heat injury may occur during cross-
clamping. 
 
Renal Protection 
Acute kidney injury after repair of rAAA is common with contributing factors 
including pre-existing renal impairment, perioperative hypovolemia, hypotension, 
aortic cross clamping and in the case of EVAR, intravenous contrast. A recent 
observational study reported the incidence of acute kidney injury after rAAA to be 
43% after open surgery and 26% after EVAR. 52 There are different models for 
defining acute kidney injury. Although acute kidney injury defined by either AKIN 
(Acute Kidney Injury Network) or RIFLE (risk, injury, failure, loss and end-stage) 
criteria is associated with higher overall mortality, the AKIN criteria is a better 
predictor of mortality in patients who are undergoing AAA surgery. 53 The use of 
the AKIN criteria for defining acute kidney injury is also advocated by the 
Vascular Society of Great Britain and Ireland. Patients with acute kidney injury 
after surgical repair of rAAA have significantly higher mortality rates, independent 
of co-morbidities and other complications. 52-54 Therefore, it is important to do 
everything possible to minimize acute kidney injury. The use of drugs such as 
dopamine, furosemide and mannitol to prevent kidney injury are not currently 
supported by any clinical evidence. The mainstay of the current renal protective 
strategy is to avoid nephrotoxic drugs, limit cross clamping time, especially 
supra-renal, and to maintain adequate perfusion by avoidance of hypotension 
and maintenance of adequate intravascular fluid volume. 
 
POSTOPERATIVE CARE 
 
All patients require postoperative transfer to ICU for further supportive care. 
Patients are at high risk of cardiac, respiratory and renal complications as well as 
intra-abdominal hypertension and ileus. Acid-base balance, electrolytes, renal 
function, coagulation and hemoglobin should be closely monitored. The lower 
limbs are closely monitored for signs of ischemia. Postoperative analgesia is a 
challenge and often an epidural is inserted after correction of the coagulopathy 
and before extubation.  Neurological deficit due to spinal cord ischemia55 is a 
rare, but devastating complication after rAAA and early diagnosis may be 
confounded by epidural use.  
 
FUTURE PERSPECTIVES FOR rAAA 
 
The endovascular revolution has changed the elective surgical management of 
patients with abdominal aortic aneurysms and the indication from recent trials is 
that it will continue to be used more widely for rAAA. 3,48,56 Ongoing development 
of endovascular graft technology is expected to further enhance the use of this 
technique.57 Future research needs to identify how the results from emergency 
EVAR for rAAA could be improved through the use of local anesthesia, fluid 
management, surgical technique such as the use of endovascular occlusion 
balloons or other measures. 48 The results from the IMPROVE trial indicated that 
women seem to benefit more than men from the endovascular approach for 
rAAA. 3 Further future challenges and areas for research include addressing the 
absence of information about target red blood cell transfusion threshold50 in this 
patient group and whether indications and management of rAAA should be 
different in women and in the elderly. 48,57 
 
 
CONCLUSIONS 
The treatment of patients who present with rAAA has recently gone through 
several changes and evolved to accommodate advancing surgical techniques, 
including the increased use of EVAR and the centralization of vascular services 
in the UK to specialist centers. Traditional perceptions of the optimal anesthetic 
management of rAAA are challenged by recent studies, such as the IMPROVE 
Trial 3,41 that has raised questions about the optimal mode of anesthesia for 
EVAR of rAAA and also the optimal hemodynamic management. 
This patient group should benefit from the introduction of national clinical 
guidelines and audit standards. A continued, collaborative approach between 
surgeons and anesthetists should aid the collection of larger data sets. Along 
with this, more prospective clinical research studies, including well designed, 
relevant randomized controlled trials are needed to inform anesthetic approach 
with regards to goal-directed hemodynamic and fluid management and also the 
optimal mode of anesthesia for EVAR of rAAA.  
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FIGURE LEGENDS 
 
Figure 1 
Suggested pathway for decision-making and management of the transfer of 
patients who present with rAAA. 
 
Figure 2 
Pathway from presentation to the operating theatre. 
 
FIGURE LEGENDS 
 
Figure 1 
Decision-making and transfer pathway for patients presenting with a ruptured 
abdominal aortic aneurysm (rAAA): 
 
Figure 2 
Patient pathway from presentation at vascular center to the operating theatre. 
 
Table 1. Risk Stratification for rAAA 
Table 1. Risk stratification for ruptured AAA 
GAS      Hardman Index    
 APACHE II      POSSUM 
Variable   Score    Variable   Score 
   Variable   Score   Variable 
Score 
Age    No. years   LOC     1   
 Temperature (°C)  0 – 4   Age (years)          1, 2, 4 or 8 
Age >76    1   Cr >190 mmol/l   1 
   MAP (mmHg)     Cardiac signs 
 
Shock    17    Hb <90g/l    1  
  Heart rate (bpm)    Respiratory Signs 
 
Myocardial disease  7   Myocardial ischaemia  1   
 Respiratory rate    SBP (mmHg) 
Cerebrovascular disease 10         
 Oxygenation     Heart rate (bpm) 
Renal disease   14         
 Arterial pH     GCS 
          
  Na
+
 (mmol/l)     Ur (mmol/l) 
 
          
  K
+
 (mmol/l)     Na
+
 (mmol/l) 
 
           
 Cr mmol/l     K
+
 (mmol/l) 
           
 Haematocrit (%)    Hb (g/l) 
           
 WCC (x 10
9
/l)     WCC (x 10
9
/l) 
           
 GCS      ECG 
           
 Age (years)     Operation category 
           
 Chronic Health Points    No. procedures 
            
     Total blood loss (ml) 
            
     Peritoneal soiling 
            
     Malignancy 
            
     Timing of operation 
Score predicting high mortality risk 
 >84  = 65% mortality    ≥2 high mortality      
30-34 = 70% mortality   % predicted mortality  
    (≥3 unlikely to survive)    >35 = 90%  
   calculated directly 
rAAA specific? 
 Yes      Yes      
 No      Yes (if RAAA-POSSUM used) 
Validated for open & EVAR repair? 
   No        Yes         
No           No 
Myocardial disease: previous myocardial infarction and/or ongoing angina; Cerebrovascular disease: includes all grades of stroke 
including transient ischaemic attack; Renal disease: serum urea> 20 mmol/l and/or creatinine >150 mmol/l; 
LOC=loss of consciousness after presentation; Cr=serum creatinine; Hb=haemoglobin; acute myocardial ischaemia defined as 
depressed ST segments >1 mm and/or associated T wave changes on electrocardiogram (ECG); MAP=mean arterial pressure; 
GCS=Glasgow Coma Score; Ur-serum urea; Na=serum sodium; WCC=white cell count; Oxygenation: A-a PO2 (FiO2>50%) or PaO2 
(FiO2<50%), A-aPO2=Alveolar-arterial gradient of partial pressure of oxygen; FiO2=fraction of inspired oxygen; PaO2=partial 
pressure of arterial oxygen; Chronic Health Points: if patient has history of severe organ system insufficiency, points are awared: for 
non-operative or emergency postoperative patients 5, for elective postoperative patients 2. 
 
 
 
 
➡ Immediately inform on-call Consultant Vascular Surgeon, Anaesthetist & Radiologist 
➡ Move patient to resuscitation area 
➡ Large bore IV access 
➡ Brief targeted pre-operative assessment 
➡ Activate major haemorrhage protocol - blood products cross matched / available 
➡ Aim to maintain SBP > 70mmHg 
➡ Inform 2nd anaesthetist to prepare theatre, drugs & equipment 
➡ If possible insert arterial line
CLINICAL DIAGNOSIS OF RUPTURED AAA 
Radiological diagnosis of ruptured AAA
➡ GA induction with surgeons scrubbed
➡ Invasive monitoring
➡ Ongoing communication including with 
haematology
MOVE TO PREPARED 
HYBRID THEATRE
DECISION NOT TO OPERATE
PATIENT STABLE
DECISION TO OPERATE
SUITABLE FOR OPEN REPAIR SUITABLE FOR EVAR
MOVE TO PREPARED 
OPERATING THEATRE
Consider LA vs GA 
discussion with patient, 
anaesthetist, surgeon, radiologist
TRANSFER TO ICU
➡ GA or LA (be ready to convert to GA)
➡ Invasive monitoring
➡ Ongoing communication including with 
haematology
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PATIENT UNSTABLE
➡ Large bore IV access 
➡ Aim to maintain SBP >70mmHg 
➡ Quickly assess clinical condition,  
co-morbidities & functional capacity 
Transfer           
contra-indicated
DIAGNOSIS OF RUPTURED 
AAA 
(clinical or radiological)
REFER WITHOUT DELAY 
TO VASCULAR CENTRE
Consultant discussion
➡ NO OTHER INVESTIGATIONS ESSENTIAL:
➡ ABG & US useful if they don’t delay
➡ CT conﬁrmation not needed
➡ Analgesia & IV ﬂuids as required
➡ Time-critical transfer - in 999 ambulance with 
paramedic crew preferable but not essential
➡ Medical escort needed if patient on inotrope support
➡ Unless transfusion already commenced, do not travel 
with blood products
➡ Analgesia & IV ﬂuids as required
ON ARRIVAL TO VASCULAR 
CENTRE
TRANSFER 
(within 30 mins of 
diagnosis)
➡ Age < 85
➡
  No / mild / moderate   
     systemic disease
➡ Age > 85
➡
  Severe systemic 
     disease
➡ Cardiac arrest
➡ Intubated
Cardiovascularly unstableCardiovascularly stable
Emergency Dept
CT
To emergency 
operating theatre
View publication stats
